Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Surgical Tubing Market Analysis

ID: MRFR//6906-HCR | 111 Pages | Author: Rahul Gotadki| May 2024

The Stem Cell Reconstructive Market is experiencing noteworthy growth, fueled by advancements in regenerative medicine and the use of stem cells for reconstructive therapies. Stem cell-based interventions have emerged as a promising approach to address a wide range of medical conditions and injuries.
Stem cells possess unique regenerative properties, making them valuable for reconstructive purposes. These cells can differentiate into various cell types, promoting tissue repair and regeneration in damaged or diseased areas of the body.
Stem cell reconstructive market is driven by the orthopedic segment. Stem cells are used in orthopedic treatment and helps bone cartilage, and soft tissue to repair the damaged section by regeneration its is a new approach for osteoarthritis as well treats muscle injury.
The application of tracts based on stem cell reconstructive therapies is highly in plastic and reconstructive surgery. Facelift, breast reconstruction and many other procedures may benefit from the use of stem cells in terms of improvement for speedy healing favorable tissue quality along with better cosmetic results.
Nationally, stem cells are critical to cardiovascular restoration. Techniques that employ stem cell therapies are intended to reduce the damage incurred on heart tissues, presenting new treatment opportunities for diseases of the heart and general improvement of cardiac function.
Some promise is seriously being shown by stem cell-based strategies in dealing with microscopic structure and spinal line lesions. Specialists try to understand the ability of stem cells repair neural tissues damaged due for example, Parkinson’s disease and spinal cord injury which restores function in patients.
Recent innovations in stem cell technologies facilitate successful reconstruction. New approaches to isolation, culture and alteration of stem cells increase their possibilities in treatments planting new horizons.
Stimulated by a dynamic environment of clinical trials and research programs for stem cells, the U.S. reconstructive market has been cordoned The scientific communities’ researches aimed at discovery of new areas for applications and increasing the numbers on evidence behind stem cell therapies launch stimulate market expansion.
The regulatory sphere within which stem cell therapies are operating changes. Monitoring bodies are in the process of devising policies to ensure that these intervention s offer safety and efficiency while providing a moderation proportionality on its usage.
The patient-driven healthcare model becomes more prominent, and the changes to that end structure stem cell reconstructive therapies. Stem cell therapy in reconstructive medicine is increasingly characterized by personalized treatment plans adjusted to individual patient needs.
Standardization is an ongoing challenge; the scalability of such therapies over long periods of time has yet to be determined. The efforts to resolve such challenges are necessary for the formation of long-lasting and trusted approaches in it.
Strategic affiliations among research centers, biotechnology companies and healthcare providers are the crux of commercializing stem cell reconstructive therapies. Such partnerships allow to convert scientific findings into implementable and available treatments.
The impact of the U.S. Stem Cell Reconstructive Market extends beyond national borders, contributing to global advancements in regenerative medicine. Collaborations and knowledge sharing on an international scale enhance the collective understanding of stem cell applications.

Surgical Tubing Market Forecast:


The surgical tubing market is anticipated to reach USD 1869.29 Million by 2030 at 7.50% CAGR during the forecast period 2022-2030


Market Synopsis


Surgical tubing is made of Latex and which is available in different diameter and thickness. There is an improvement in the quality of surgical tubing in the past few years, which is fueling the global market growth. Also, as surgical tubing is used for various surgical purposes, moreover, companies are investing in this market.


Market Influencer


Growing awareness and government initiatives to provide advanced healthcare facilities to the market growth will boost the market growth.


Market Drivers



  • Growing in geriatric population worldwide. About 185 million people were above 60 years of age in 2015 (15.7% of the population), and this number is expected to touch 487 million by 2053 (36.5% of the population) with a rising geriatric population. Moreover, around 857,040 older population is likely to reside in Asia by 2050.

  • Shift toward the minimally invasive medical procedure

  • Increasing demand for surgical devices that includes tubing

  • Growing funding by government organizations


Market Restraints



  • Stringent regulatory policies

  • Significant investment and time required for product development


Segmentation


By Material



  • Polyvinyl Chloride (PVC): It is expected to hold the largest share, owing to the wide range of application it offers.

  • Thermoplastic Elastomer (TPE): These are a mixture of synthetic materials and has high potential for recyclability.

  • Thermoplastic Polyurethane (TPU): They are class of polyurethane with many properties such as transparency, elasticity, and resistance to grease, oil, and abrasion. TPU is the fastest growing market due to unique properties of plastics.

  • Silicone: Silicone rubber tubing having various medical applications such as medical use like high-purity pressure tubing, medical/surgical tubing.

  • Polyolefins: Polyolefins are further segmented into polyethylene (PE) and polypropylene (PP).

  • Polyolefins are commonly used in surgical instruments such as electrotomes and endoscopes.

  • Others: the others segment includes various products such as polyether ether ketone (PEEK), polyamide (NYLON), fluoropolymer, polycarbonate (PC), bioabsorbable polymers, among others.


By Structure



  • Single-Lumen: It is expected to hold the largest share, due to the widely used worldwide.

  • Multi-Lumen: These are generally custom made, laser machined and kink resistant. Multi-lumen is fastest-growing segment during the forecast period

  • Braided Tubing: Braided tubing is used in various surgical instruments.

  • Balloon Tubing: In balloon tubing, high-pressure balloons are used for various diagnostic and therapeutic procedures.

  • Others: The others segment includes various products such as heat shrink tubing, tapered or bump tubing, co-extruded, and among others


By Application



  • Orthopedic surgery: This is expected to be the largest segment, owing to the increasing number of orthopedic surgeries worldwide.

  • Neurosurgery: The increasing number of different neurosurgery cases is projected to push this segment to be the fastest-growing. Moreover, the share of this segment is expected to increase owing to the rising patient population.

  • Trauma Surgery: Traumatic brain injuries treatment (TBI) is an interruption in the normal function of the brain. It is a serious public health problem and is the leading cause of brain injury with at least 1.7 million people sustaining such injury every year. Traumatic brain injuries contribute to a substantial number of death and permanent disability every year

  • Ophthalmological Surgery: It includes surgery performed on the eye or its adnexa, typically by an ophthalmologist.

  • Others: The others segment include toxicology and autoimmune diseases, among others.


By End-User



  • Hospitals and Clinics: The largest segment, hospitals, and clinics are usually the primary points for diagnosis and treatment of individuals. Growing awareness about new products and increasing use of surgical equipment are projected to drive the growth of this segment during the forecast period.

  • Ambulatory Surgical Centers: Ambulatory surgical centers (ASC) provide outpatient procedures to patients who do not require an overnight stay after the procedure. In 2016, nearly 3.4 million fee-for-service (FFS) Medicare beneficiaries were treated in 5,532 ASCs certified to provide services to Medicare beneficiaries. Medicare program and beneficiary spending on ASC services was about USD 4.3 billion in the same year. From 2015 to 2016, the number of ASCs increased by 1.4% to 5,532. The annual growth rate was similar from 2015 to 2018 but slower than the prior period. In 2016, the number of new ASCs increased by 142, while 63 ASCs got closed or merged with other facilities. Since 2006, the number of new ASCs had been outnumbering ASCs that closed or merged, leading to a 23% increase in the number of ASCs from 2006 to 2016.

  • Others: This segment includes research organizations and academic institutions.


By Region



  • Americas: The largest regional market. Countries such as the US and Canada have well-established of advanced healthcare facilities in the region. This contributes to the growth of surgical tubing market in this region.



  • Europe: Europe is expected to hold the second-largest position in the global surgical tubing market owing to the presence of major market players in the European countries.



  • Asia-Pacific: Asia-Pacific region is anticipated to be the fastest-growing region in the global surgical tubing market. This region is seeing a surge in the number of people afflicted with chronic diseases.



  • Middle East & Africa: The smallest market due to limited healthcare infrastructure and limited exposure to technological advancements.


Key Players



  • Zeus Industrial Products (US)

  • Saint-Gobain Performance Plastics (France)

  • Teleflex (US)

  • Raumedic (Germany)

  • Tekni-Plex (US)

  • L.Gore & Associates (US)

  • Kent Elastomer Products, Inc. (US)

  • P. Extrusion (US)

  • Freudenberg Group (Germany)

  • Grayline (US)

  • Microlumen (US)

  • Polyzen (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.